Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required)
Funding Opportunity RFA-HL-22-014 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) participating Institutes and Centers, in coordination with the U.S. Food and Drug Administration (FDA), seeks highly meritorious clinical trial applications proposing to explore and enable the development of safe and effective regenerative medicine (RM) interventions using adult stem cells. This Funding Opportunity Announcement (FOA), issued as part of the Regenerative Medicine Innovation Project (RMIP), represents one step in fulfilling a statutory provision set forth in the 21st Century Cures Act. App...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 13, 2021 Category: Research Source Type: funding
Program on the Origins of Gastroesophageal Cancers (R01 Clinical Trial Optional)
Funding Opportunity RFA-CA-21-026 from the NIH Guide for Grants and Contracts. The National Cancer Institute (NCI) is publishing this Funding Opportunity Announcement (FOA) to request applications for the Program on the Origins of Gastroesophageal Cancers (R01). This new program will build on recent molecular classifications of gastroesophageal cancers, significant understanding of their cancer genomics, and advances in stem cell research to examine and define how these related cancers initially evolve at the cellular level. The program will address the complex mechanisms and effectors that direct the proliferation and ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 25, 2021 Category: Research Source Type: funding
Coordinating Center for the Program on the Origins of Gastroesophageal Cancers (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-21-027 from the NIH Guide for Grants and Contracts. The National Cancer Institute (NCI) is publishing this Funding Opportunity Announcement (FOA) to request applications for the Coordinating Center, Program on the Origins of Gastroesophageal Cancers (U24). This new program will build on recent molecular classifications of gastroesophageal cancers, significant understanding of their cancer genomics, and advances in stem cell research to examine and define how these related cancers initially evolve at the cellular level. The program will address the complex mechanisms and effectors that direct t...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 25, 2021 Category: Research Source Type: funding
Organoid Modeling of Neural Stimulants and HIV Comorbidity of Human Brain (R01- Clinical Trial Optional)
Funding Opportunity RFA-DA-22-009 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications to study mechanisms underlying the neuropathophysiology of HIV-associated neurological disorders (HAND) using induced microglia and cerebral organoids generated from human derived induced pluripotent stem cell (iPSC) lines. Specific emphasis is on the comorbidity of HIV and neural stimulants, including amphetamine, methamphetamine, cocaine, and nicotine, studied at the single cell and neural circuits levels. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 17, 2021 Category: Research Source Type: funding
Notice of Biospecimen Sharing Policy for the National Institute of Mental Health, Including Requirements for Induced Pluripotent Stem Cell Resource Development and Sharing
Notice NOT-MH-21-265 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 11, 2021 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Characterization of Genomics of Induced Pluripotent Stem Cell Lines for AD/ADRD Research
Notice NOT-NS-21-041 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 23, 2021 Category: Research Source Type: funding
Early-Phase Clinical Trials of Novel Interventions to Prevent, Delay, or Treat Aging-Related Conditions by Targeting Aging-Related Mechanisms (U01 Clinical Trial Required)
Funding Opportunity RFA-AG-22-011 from the NIH Guide for Grants and Contracts. NIA invites applications for Phase 1, 2a, and 2b clinical trials of new compounds or re-purposed existing drugs, biologics (except stem cells), or supplements to treat multiple chronic conditions by modulating fundamental aging-related mechanisms as well as to test compounds that could affect the individual diseases and conditions disproportionally affecting older adults. This FOA is not intended to provide support for definitive efficacy and safety trials. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 3, 2021 Category: Research Source Type: funding
NEI Collaborative Clinical Vision Project: Resource Center Grant (UG1- Clinical Trial Required)
Funding Opportunity PAR-21-043 from the NIH Guide for Grants and Contracts. The NEI uses UG1 cooperative agreement awards to support investigator-initiated large-scale clinical trials, human gene-transfer and stem cell therapy trials, and other complex or high resource- or safety-risk clinical trials. These projects are multifaceted and of high public health significance, requiring clear delineation of study organization including roles and responsibilities and require careful performance oversight and monitoring for patient safety. For purposes of this Funding Opportunity Announcement (FOA), the proposed study must be ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 18, 2020 Category: Research Source Type: funding
NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinical Trial Required)
Funding Opportunity PAR-21-042 from the NIH Guide for Grants and Contracts. The NEI uses UG1 cooperative agreement awards to support investigator-initiated large-scale clinical trials, human gene-transfer and stem cell therapy trials, and other complex or high resource- or safety-risk clinical trials. These projects are multifaceted and of high public health significance, requiring clear delineation of study organization including roles and responsibilities and require careful performance oversight and monitoring for patient safety. For purposes of this Funding Opportunity Announcement (FOA), the proposed study must be ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 18, 2020 Category: Research Source Type: funding
NEI Collaborative Clinical Vision Research : Chair's Grant (UG1-Clinical Trial Required)
Funding Opportunity PAR-21-041 from the NIH Guide for Grants and Contracts. The NEI uses UG1 cooperative agreement awards to support investigator-initiated large-scale clinical trials, human gene-transfer and stem cell therapy trials, and other complex or high resource- or safety-risk clinical trials. These projects are multifaceted and of high public health significance, requiring clear delineation of study organization including roles and responsibilities and require careful performance oversight and monitoring for patient safety. For purposes of this Funding Opportunity Announcement (FOA), the proposed study must be ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 18, 2020 Category: Research Source Type: funding
Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required)
Funding Opportunity RFA-HL-21-003 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) participating Institutes and Centers, in coordination with the U.S. Food and Drug Administration (FDA), seeks highly meritorious clinical trial applications proposing to explore and enable the development of safe and effective regenerative medicine (RM) interventions using adult stem cells. This Funding Opportunity Announcement (FOA), issued as part of the Regenerative Medicine Innovation Project (RMIP), represents one step in fulfilling a statutory provision set forth in the 21st Century Cures Act. App...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 2, 2020 Category: Research Source Type: funding
Notice of Change in Topic Areas of Interest for NOT-HL-20-761, Notice of Special Interest (NOSI): Pulmonary Complications of Hematopoietic Stem Cell Transplantation in Childhood
Notice NOT-HL-20-790 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 5, 2020 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Pulmonary Complications of Hematopoietic Stem Cell Transplantation in Childhood
Notice NOT-HL-20-761 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 27, 2020 Category: Research Source Type: funding
Pre-call announcement: UK-Japan Regenerative Medicine and Stem Cell Research Initiative
(Source: MRC Funding Opportunities)
Source: MRC Funding Opportunities - October 31, 2019 Category: Research Source Type: funding
MRC-AMED Regenerative Medicine and Stem Cell Research Initiative
(Source: MRC Funding Opportunities)
Source: MRC Funding Opportunities - October 31, 2019 Category: Research Source Type: funding
